• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与人纤维蛋白形成的四个不同聚合位点的证据。

Evidence for four different polymerization sites involved in human fibrin formation.

作者信息

Olexa S A, Budzynski A Z

出版信息

Proc Natl Acad Sci U S A. 1980 Mar;77(3):1374-8. doi: 10.1073/pnas.77.3.1374.

DOI:10.1073/pnas.77.3.1374
PMID:6929491
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC348497/
Abstract

The mechanism of association and the organization of human fibrin were studied by using affinity chromatography. Insolubilized fibrinogen, fibrin monomer, and crosslinked fibrin were used to localize the binding sites on fibrinogen and fibrin derivatives. Four different polymerization sites have been distinguished. A binding site ("a"), available without thrombin action, is present on the fibrinogen fragment D domain. The complementary ("A") is inoperative in fibrinogen and requires thrombin for activation; it is located on the fibrinogen NH2-terminal domain. A third polymerization site ("b") appears to be formed by the alignment of the fragment D domains on two fibrin monomer molecules upon polymerization; this site functions without thrombin mediation and the alignment is stabilized by the Factor XIIIa-catalyzed crosslink bonds. The "b" site is complementary to another thrombin-activated site ("B") on the fibrinogen NH2-terminal domain. The two thrombin activable sites, "A" and "B", are distinguishable, although they are located in the same fibrinogen domain.

摘要

利用亲和色谱法研究了人纤维蛋白的缔合机制和组织结构。使用不溶性纤维蛋白原、纤维蛋白单体和交联纤维蛋白来定位纤维蛋白原和纤维蛋白衍生物上的结合位点。已区分出四个不同的聚合位点。一个无需凝血酶作用即可利用的结合位点(“a”)存在于纤维蛋白原D片段结构域上。互补位点(“A”)在纤维蛋白原中不起作用,需要凝血酶激活;它位于纤维蛋白原的NH2末端结构域。第三个聚合位点(“b”)似乎是在聚合时由两个纤维蛋白单体分子上的D片段结构域排列形成的;该位点在无凝血酶介导的情况下起作用,并且这种排列通过因子XIIIa催化的交联键得以稳定。“b”位点与纤维蛋白原NH2末端结构域上的另一个凝血酶激活位点(“B”)互补。两个可被凝血酶激活的位点,“A”和“B”,尽管位于同一纤维蛋白原结构域中,但却是可区分的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad00/348497/5dddefbddf80/pnas00666-0154-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad00/348497/5dddefbddf80/pnas00666-0154-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad00/348497/5dddefbddf80/pnas00666-0154-a.jpg

相似文献

1
Evidence for four different polymerization sites involved in human fibrin formation.参与人纤维蛋白形成的四个不同聚合位点的证据。
Proc Natl Acad Sci U S A. 1980 Mar;77(3):1374-8. doi: 10.1073/pnas.77.3.1374.
2
The structure and biological features of fibrinogen and fibrin.纤维蛋白原和纤维蛋白的结构与生物学特性。
Ann N Y Acad Sci. 2001;936:11-30. doi: 10.1111/j.1749-6632.2001.tb03491.x.
3
Conversion of fibrinogen to fibrin induced by preferential release of fibrinopeptide B.纤维蛋白肽B的优先释放诱导纤维蛋白原向纤维蛋白的转化。
Biochim Biophys Acta. 1989 Jan 27;990(1):18-24. doi: 10.1016/s0304-4165(89)80006-6.
4
Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.瓜氨酸化纤维蛋白原在凝血酶催化的纤维蛋白肽A和纤维蛋白肽B释放以及纤维蛋白聚合方面存在缺陷。
Clin Chim Acta. 2009 Mar;401(1-2):119-23. doi: 10.1016/j.cca.2008.12.002. Epub 2008 Dec 6.
5
Sialic acid in fibrinogen: effects of sialic acid on fibrinogen-fibrin conversion by thrombin and properties of asialofibrin clot.纤维蛋白原中的唾液酸:唾液酸对凝血酶介导的纤维蛋白原 - 纤维蛋白转化的影响及去唾液酸纤维蛋白凝块的特性
Biol Pharm Bull. 1993 May;16(5):448-52. doi: 10.1248/bpb.16.448.
6
B:b interactions are essential for polymerization of variant fibrinogens with impaired holes 'a'.B:b相互作用对于具有受损“a”孔的变异纤维蛋白原的聚合至关重要。
J Thromb Haemost. 2007 Dec;5(12):2352-9. doi: 10.1111/j.1538-7836.2007.02793.x. Epub 2007 Oct 8.
7
Interaction of thrombin and fibrinogen and the polymerization of fibrin monomer.凝血酶与纤维蛋白原的相互作用以及纤维蛋白单体的聚合。
Ann N Y Acad Sci. 1983 Jun 27;408:330-43. doi: 10.1111/j.1749-6632.1983.tb23255.x.
8
A unique property of a plasma proteoglycan, the C1q inhibitor. An anticoagulant state resulting from its binding to fibrinogen.血浆蛋白聚糖C1q抑制剂的一种独特特性。其与纤维蛋白原结合导致抗凝状态。
J Clin Invest. 1994 Jan;93(1):303-10. doi: 10.1172/JCI116960.
9
[Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].[纤维蛋白原与两种经凝血酶激活程度不同的纤维蛋白形式之间的相互作用]
Biokhimiia. 1985 Aug;50(8):1336-41.
10
Fibrin polymerization and release of fibrinopeptide B by thrombin.凝血酶介导的纤维蛋白聚合及纤维蛋白肽B的释放。
Thromb Res. 1982 Aug 15;27(4):419-27. doi: 10.1016/0049-3848(82)90059-7.

引用本文的文献

1
The Non-catalytic B Subunit of Coagulation Factor XIII Accelerates Fibrin Cross-linking.凝血因子 XIII 的非催化 B 亚基可加速纤维蛋白交联。
J Biol Chem. 2015 May 8;290(19):12027-39. doi: 10.1074/jbc.M114.608570. Epub 2015 Mar 25.
2
A recombinant fragment of von Willebrand factor reduces fibrin-rich microthrombi formation in mice with endotoxemia.血管性血友病因子的重组片段可减少内毒素血症小鼠中富含纤维蛋白的微血栓形成。
Thromb Res. 2015 May;135(5):1025-30. doi: 10.1016/j.thromres.2015.02.033. Epub 2015 Mar 3.
3
Polymerization of fibrin: Direct observation and quantification of individual B:b knob-hole interactions.

本文引用的文献

1
Fibrinase. I. Purification of substrate and enzyme.纤维蛋白酶。一、底物与酶的纯化。
J Biol Chem. 1961 Oct;236:2625-33.
2
DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.圆盘电泳。II. 方法及其在人血清蛋白中的应用。
Ann N Y Acad Sci. 1964 Dec 28;121:404-27. doi: 10.1111/j.1749-6632.1964.tb14213.x.
3
The fibrinogen molecule: its size, shape, and mode of polymerization.纤维蛋白原分子:其大小、形状及聚合模式。
纤维蛋白的聚合:单个Bβ链球-孔相互作用的直接观察与定量分析
Blood. 2007 Jan 1;109(1):130-8. doi: 10.1182/blood-2006-07-033910. Epub 2006 Aug 29.
4
Studies on the basis for the properties of fibrin produced from fibrinogen-containing gamma' chains.关于含γ'链纤维蛋白原产生的纤维蛋白特性基础的研究。
Blood. 2005 Oct 15;106(8):2730-6. doi: 10.1182/blood-2005-01-0240. Epub 2005 Jul 7.
5
Structure and function of human fibrinogen inferred from dysfibrinogens.从异常纤维蛋白原推断人类纤维蛋白原的结构与功能
Int J Hematol. 2002 Aug;76 Suppl 1:352-60. doi: 10.1007/BF03165284.
6
A double-headed Gly-Pro-Arg-Pro ligand mimics the functions of the E domain of fibrin for promoting the end-to-end crosslinking of gamma chains by factor XIIIa.一种双头甘氨酰-脯氨酰-精氨酰-脯氨酸配体模拟纤维蛋白E结构域的功能,以促进因子XIIIa介导的γ链的端到端交联。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):537-41. doi: 10.1073/pnas.95.2.537.
7
The primary fibrin polymerization pocket: three-dimensional structure of a 30-kDa C-terminal gamma chain fragment complexed with the peptide Gly-Pro-Arg-Pro.主要纤维蛋白聚合口袋:与肽Gly-Pro-Arg-Pro复合的30 kDa C末端γ链片段的三维结构
Proc Natl Acad Sci U S A. 1997 Jul 8;94(14):7176-81. doi: 10.1073/pnas.94.14.7176.
8
Molecular basis for fibrinogen Dusart (A alpha 554 Arg-->Cys) and its association with abnormal fibrin polymerization and thrombophilia.纤维蛋白原杜萨特(Aα554精氨酸→半胱氨酸)的分子基础及其与异常纤维蛋白聚合和血栓形成倾向的关联。
J Clin Invest. 1993 Apr;91(4):1637-43. doi: 10.1172/JCI116371.
9
Fibrinogen Osaka IV: a congenital dysfibrinogenemia found in a patient originally reported in relation to surgery, now defined to have an A alpha arginine-16 to histidine substitution.大阪纤维蛋白原IV型:一种先天性异常纤维蛋白原血症,最初在一名与手术相关的患者中发现,现确定存在α-A链精氨酸16被组氨酸替代的情况。
Surg Today. 1993;23(1):45-50. doi: 10.1007/BF00308999.
10
The role of fibrinogen D domain intermolecular association sites in the polymerization of fibrin and fibrinogen Tokyo II (gamma 275 Arg-->Cys).纤维蛋白原D结构域分子间缔合位点在纤维蛋白和纤维蛋白原东京II(γ275精氨酸→半胱氨酸)聚合中的作用
J Clin Invest. 1995 Aug;96(2):1053-8. doi: 10.1172/JCI118091.
J Biophys Biochem Cytol. 1959 Jan 25;5(1):11-6. doi: 10.1083/jcb.5.1.11.
4
The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳测定分子量的可靠性。
J Biol Chem. 1969 Aug 25;244(16):4406-12.
5
Fibrinogen Detroit--a molecular defect in the N-terminal disulphide knot of human fibrinogen?纤维蛋白原底特律——人类纤维蛋白原N端二硫键结中的分子缺陷?
Nature. 1968 Apr 13;218(5137):134-7. doi: 10.1038/218134a0.
6
The purification of fibrinogen degradation products by pevikon block electrophoresis.用聚乙烯醇缩甲乙醛阻滞电泳法纯化纤维蛋白原降解产物
Thromb Diath Haemorrh. 1969 Nov 15;22(2):234-9.
7
Structural aspects of the fibrinogen to fibrin conversion.纤维蛋白原向纤维蛋白转化的结构方面。
Adv Protein Chem. 1973;27:1-109. doi: 10.1016/s0065-3233(08)60446-5.
8
Defect in the gamma polypeptide chain of a congenital abnormal fibrinogen (Paris I).先天性异常纤维蛋白原(巴黎I型)γ多肽链缺陷
Nature. 1974 Nov 1;252(5478):66-8. doi: 10.1038/252066a0.
9
N-terminal disulphide knot of human fibrinogen.人纤维蛋白原的N端二硫键结
Nature. 1968 Apr 13;218(5137):130-4. doi: 10.1038/218130a0.
10
Evidence for localization of polymerization sites in fibrinogen.纤维蛋白原中聚合位点定位的证据。
J Biol Chem. 1974 May 25;249(10):3322-5.